Lethal form of a late-onset aquaporin-4 antibody-positive NMOSD related to the immune checkpoint inhibitor nivolumab

Saved in:
Bibliographic Details
Published inJournal of neurology Vol. 269; no. 5; pp. 2778 - 2780
Main Authors Weiss, David, Cantré, Daniel, Zettl, Uwe K., Storch, Alexander, Prudlo, Johannes
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.05.2022
Springer Nature B.V
Subjects
Aquaporin 4
Autoantibodies
Humans
Immune checkpoint
Immune Checkpoint Inhibitors - adverse effects
Letter to the Editors
Medicine
Medicine & Public Health
Neurology
Neuromyelitis Optica - diagnostic imaging
Neuromyelitis Optica - drug therapy
Neuroradiology
Neurosciences
Nivolumab - adverse effects
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0340-5354
1432-1459
DOI:10.1007/s00415-021-10913-y